Re the article: "Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. On behalf of the EORTC Radiation Oncology and Breast Cancer Groups. Radiother Oncol 2009;90:80-5"

Comment

Anusheel Munshi. Radiother Oncol. 2010 Jan.

. 2010 Jan;94(1):118; author reply 118-9.

doi: 10.1016/j.radonc.2009.08.022. Epub 2009 Sep 10.

No abstract available

Comment on

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
Poortmans PM, Collette L, Horiot JC, Van den Bogaert WF, Fourquet A, Kuten A, Noordijk EM, Hoogenraad W, Mirimanoff RO, Pierart M, Van Limbergen E, Bartelink H; EORTC Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Radiother Oncol. 2009 Jan;90(1):80-5. doi: 10.1016/j.radonc.2008.07.011. Epub 2008 Aug 15. Radiother Oncol. 2009. PMID: 18707785 Clinical Trial.